rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Alison Cecily Finger

Director

Company insider

Files Form 4 as: Director, ADMA Biologics; Director, Decibel Therapeutics; Chief Commercial Officer, bluebird bio.

Every Form 4 they filed

In numbers

Trades disclosed
48
Buys
0
Sells
15
Bought
$0
Sold
$440K
Companies
3
Companies where not an officer
2
First trade
20 Aug 2018
Last trade
9 Feb 2026
Last filed
11 Feb 2026

Companies traded

Where they are an officer
bluebird bioOfficer · last 6 Jan 20210 buys · 15 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ADMA ADMA BiologicsDirector · Biotechnology · last 9 Feb 20260 buys · 0 sells
Decibel TherapeuticsDirector · last 25 Sep 20230 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Feb 2026filed 11 Feb 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code A—10,690 at $0.00filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—17,730 at $0.00filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—17,730 at $0.00filing
9 Feb 2026filed 11 Feb 2026ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code A—10,690 at $0.00filing
19 Feb 2025filed 21 Feb 2025ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—16,279 at $0.00filing
19 Feb 2025filed 21 Feb 2025ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code A—10,889 at $0.00filing
26 Feb 2024filed 28 Feb 2024ADMA ADMA Biologicsoption or derivative · BiotechnologySEC FORM 4 Code A—37,541 at $0.00filing
26 Feb 2024filed 28 Feb 2024ADMA ADMA BiologicsBiotechnologySEC FORM 4 Code A—24,040 at $0.00filing
25 Sep 2023filed 25 Sep 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code D—10,000filing
25 Sep 2023filed 25 Sep 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code D—5,000filing
25 Sep 2023filed 25 Sep 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code D—20,000filing
25 Sep 2023filed 25 Sep 2023Decibel TherapeuticsSEC FORM 4 Code D—5,000filing
13 Jun 2023filed 14 Jun 2023Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—5,000 at $0.00filing
13 Jun 2023filed 14 Jun 2023Decibel TherapeuticsSEC FORM 4 Code A—5,000 at $0.00filing
17 Jun 2022filed 21 Jun 2022Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—10,000 at $0.00filing
3 Dec 2021filed 6 Dec 2021Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
6 Jan 2021filed 8 Jan 2021bluebird bioSEC FORM 4 Sold$47K1,055 at $44.76filing
6 Jan 2021filed 8 Jan 2021bluebird bioSEC FORM 4 Sold$35K759 at $45.46filing
5 Jan 2021filed 8 Jan 2021bluebird bioSEC FORM 4 Sold$1,79840 at $44.95filing
2 Dec 2020filed 4 Dec 2020bluebird bioSEC FORM 4 Sold$1,61735 at $46.19filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed15

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.